VERA Overview
Upcoming Projects (VERA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VERA)
-
A Second Opinion: Looking at Vera Therapeutics 96-week eGFR Stabilization data in the ORIGIN Phase 2b Study of Atacicept in IgAN
Ticker: VERA
Executed On: Oct 31, 2024 at 04:00 PM EDT -
Looking at Vera Therapeutics 96-week eGFR Stabilization data in the ORIGIN Phase 2b Study of Atacicept in IgAN
Ticker: VERA
Executed On: Oct 30, 2024 at 10:40 AM EDT -
Evaluating Atacicept in the Treatment of Immunoglobulin A Nephropathy (IgAN): Insights from Vera Therapeutics' Phase 2b ORIGIN Study
Ticker: VERA
Executed On: Jan 03, 2024 at 02:30 PM EST -
Digging into the ORIGIN trial data for Vera's atacicept in treating immunoglobulin A nephropathy (IgAN)
Ticker: VERA
Executed On: Jan 27, 2023 at 02:30 PM EST -
A Discussion of ET and APRIL/BAFF targets in IgAN
Tickers: KDNY, TVTX, VERA
Executed On: Jul 26, 2022 at 10:00 AM EDT
Upcoming & Overdue Catalysts (VERA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (VERA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
